Even after implementing all of ASPEN's shortage mitigation recommendations for MVI products, we will likely run out of Pediatric Infuvite and Adult Infuvite in the next 2 weeks. Our inventory RPh is being told by the manufacturer that it might be June before we can get more product. So, it looks like we will end up needing to purchase the individual components recommended by ASPEN: thiamine, ascorbic acid, pyridoxine, and folic acid. For neonates, the dose volume of each ingredient is going to be immeasurable (e.g., 0.0084 mL of folic acid). Has anyone come up with a strategy for this?

Hi,

DNV requires dantrolene to be immediately available in areas where MH trigger agents are used. One identified MH trigger agent is succinylcholine, which we keep in intubation kits in ICUs and procedural areas. It would not be feasible for us to store dantrolene in all locations that may use succinycholine.

How does your hospital ensure compliance with this regulation? In which areas do you store dantrolene?

Thank you in advanced.

Sarah

We have been running into an potential problem when it comes to units of measure, and wanted to see what others are doing in children’s hospitals and especially children’s hospitals within adult hospitals. Especially interested if you use Cerner and/or DoseEdge.

Trying to figure out a plan how to roll out vaccination for "healthy" inpatients upon discharge. Whereas fist dose administration might not present a huge challenge (can follow workflow for Influenza vaccine) how is your institution planning to assure second vaccine dose to an already released person? Does any organization have a plan yet?

Trying to figure out a plan how to roll out vaccination for "healthy" inpatients upon discharge. Whereas fist dose administration might not present a huge challenge (can follow workflow for Influenza vaccine) how is your institution planning to assure second vaccine dose to an already released person? Does any organization have a plan yet?

I am located in NC and am curious how other health systems across the country are currently documenting administration of Covid vaccine. Our vaccines are currently being offered to team members and established patients in our health system with plans to open it up to the general public regardless of where their PCP is located. For team members and established patients we are double documenting--once on the state required registry and then in the patient's EMR record. How are others documenting? Are you documenting in multiple locations as well?

We are re-evaluating our processes around Closed System Drug-Transfer Devices (CSTD). I am curious to hear of other institutional approaches to non-IV routes:

Do you use the same CSTD system across your enterprise for consistency, or a different one to distinguish?

In particular I am thinking of intravesicular, intramuscular, and/or Subcutaneous routes.

Hello,
I was wondering if anyone had recommendations for resources to access medication-safety-related literature for free.

For those children's hospitals that are a hospital within an adult hospital and users of EPIC:

We have had multiple medication events due to sharing a medication formulary with the adult hospital. Please let me know if anyone using EPIC has been able to create and maintain a separate pediatric medication formulary within your organization. Has any other institution experienced errors relating back to a shared formulary?

Hi all,

Quick query-

Any institutions out there that allow nicardipine infusions on acute care floors?

I am thinking something like: tele monitored, provider to titrate on acute care floors.

Thank you,

John Dempsey, PharmD, MHA
Medication Safety Pharmacist
Harborview Medical Center
Seattle, WA
Box 359885
Phone 206-744-6043